Current Applications for Overcoming Resistance to Targeted Therapies
Targeted therapies were initially developed to exploit the upregulation and dependence on key oncogenic pathways critical to cancer progression. Additionally, they also presented as a method to overcome chemoresistance by supplementing conventional therapeutic regimens with targeted therapies. Howev...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
Έκδοση: | 1st ed. 2019. |
Σειρά: | Resistance to Targeted Anti-Cancer Therapeutics,
20 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Introduction to the Acquisition of Resistance to Targeted Therapy
- Targeting the Tumor Microenvironment to Overcome Resistance to Targeted Therapy
- Current Challenges and Applications of Oncolytic Viruses in Overcoming Resistance to Therapies in Cancer
- Novel Methods to Overcome Acquired Resistance to Immunotherapy
- Therapies to Overcome Multidrug-Resistant Receptors
- Overcoming Resistance to PARP Inhibition
- Novel Methods of Overcoming HER2 Therapy Resistance in Breast Cancer
- Emerging Novel Therapies for Overcoming Resistance to Targeted Therapies
- Targeting Epigenetic Regulators in Cancer to Overcome Resistance to Targeted Therapy
- Nanomedicine and Drug Delivery Systems in Overcoming Resistance to Targeted Therapy
- Index.